Agilent/Varian, Inc. deal
This article was originally published in The Gray Sheet
Executive Summary
Agilent will pay $1.5 billion, or $52 per share, for scientific instrumentation marketer Varian, Inc. (not to be confused with Varian Medical Systems), the firms announced July 27. The acquisition will establish Agilent as a leader in nuclear magnetic resonance, imaging and vacuum technologies and expand its presence in atomic and molecular spectroscopy, according to the company. The deal is expected to close by year end, after which Agilent CFO Adrian Dillon will be responsible for integrating Varian into Agilent's Bio-Analytical Measurement division. The elimination of duplicate operations following the merger is expected to generate $75 million in annual savings, Agilent said
You may also be interested in...
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.
Xaira Launches With $1bn-Plus And End-To-End AI Strategy
ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.